Breaking
Friday, June 19, 2026

Investment

🇺🇸 FDA Page 2

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Unlock global pharma investment opportunities. Get expert analysis on market trends, M&A, VC funding, and biotech deals for strategic decision-making.

Showing 13–24 of 25 articles

Medium impact AnalysisMay 21, 2026

Immunovant Shares Surge on Arthritis Trial Data: What It Means for Pharma

arthritis · 2 min

Dr. Sarah Mitchell
High impact NewsMay 15, 2026

BioMed Israel 2024: Key Innovations and US Partnerships

general · 8 min

Dr. Laura Bennett
Critical impact NewsMay 15, 2026

BioMed Israel 2026: Top Innovations & US Implications

general · 8 min

Dr. Laura Bennett
High impact NewsMay 13, 2026

BioMed Israel 2026: Key US Biotech Trends - Day 1 Roundup

general · 5 min

Dr. Laura Bennett
Critical impact NewsMay 13, 2026

BioMed Israel 2026: Key Takeaways for US Biotech Investors

general · 8 min

Dr. Laura Bennett
Standard impact AnalysisMay 2, 2026

FDA Scrutiny Post-Market Data: Impact on Pharma Investment Strategies

FDA · 7 min

Dr. Yuna Park
High impact NewsMay 2, 2026

ARCHIMED Acquires Esperion Therapeutics in Strategic Cardiometabolic Deal

cardiometabolic and rare/orphan diseases · 3 min

Dr. Laura Bennett
Critical impact NewsApr 29, 2026

Pharma Partnering US: Biotech Dealmaking Heats Up

biotech · 8 min

Dr. Sarah Mitchell
Critical impact NewsApr 29, 2026

Pharma Partnering US: Biotech Deals & Investment Trends Day 1

biotech · 8 min

Dr. Sarah Mitchell
Critical impact NewsApr 28, 2026

FDLI 2026: FDA Leaders to Discuss Strategic Priorities

general · 3 min

Dr. Sarah Mitchell
Critical impact NewsApr 23, 2026

BioNJ BioPartnering Conference 2026: Biotech & Partnering

biotech · 4 min

Dr. Sarah Mitchell
High impact NewsApr 23, 2026

Fierce Biotech Week 2026: What to Expect in Boston

biotech · 8 min

Dr. Sarah Mitchell